---
figid: PMC9427288__DM2022-1360954.002
pmcid: PMC9427288
image_filename: DM2022-1360954.002.jpg
figure_link: /pmc/articles/PMC9427288/figure/fig2/
number: Figure 2
figure_title: ''
caption: 'Metabolic pathway map of 5-FU. Abbreviations: 5-FU: 5-Fluorouracil; CES1:
  recombinant carboxylesterase 1; UPP1: uridine phosphorylase 1; 5′-dFCR: 5′-deoxy-5-fluorocytidine;
  CDA: cytidine deaminase; TYMP: thymidine phosphorylase; DPYS: dihydropyrimidinase;
  FUPA: 5-fluorouracil-hydantoic-acid; UPB1: recombinant beta-ureidopropionase; TK1:
  thymidine kinase 1; UMPS: uridine monophosphate synthetase; PPAT: phosphoribosyl
  pyrophosphate amido transferase; DHFU: dihydrofluorouracil; FUR: fluorouridine;
  FUMP: fluorouridine monophosphate; FUDP: fluorouridine diphospho; FUTP: fluorouridine
  triphosphate; FdUDP: fluorodeoxyuridine diphospho; FdUMP: fluorodeoxyuridine monophosphate;
  FdUTP: fluorodeoxyuridine triphosphate; dUMP: deoxy-uridine monophosphate; and dTMP:
  deoxy-thymidine monophosphate.'
article_title: A Systematic Review of Clinical Validated and Potential miRNA Markers
  Related to the Efficacy of Fluoropyrimidine Drugs.
citation: Xiaomeng Sun, et al. Dis Markers. 2022;2022:1360954.
year: '2022'

doi: 10.1155/2022/1360954
journal_title: Disease Markers
journal_nlm_ta: Dis Markers
publisher_name: Hindawi

keywords:
---
